Logo image of SUNS

SUNRISE REALTY TRUST INC (SUNS) Stock Fundamental Analysis

USA - NASDAQ:SUNS - US8679811021 - REIT

9.72 USD
+0.31 (+3.29%)
Last: 10/20/2025, 8:17:41 PM
Fundamental Rating

6

SUNS gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 66 industry peers in the Mortgage Real Estate Investment Trusts (REITs)" industry. While SUNS belongs to the best of the industry regarding profitability, there are concerns on its financial health. SUNS is not overvalued while it is showing excellent growth. This is an interesting combination.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

SUNS had positive earnings in the past year.
In the past year SUNS has reported a negative cash flow from operations.
Each year in the past 5 years SUNS has been profitable.
SUNS had a positive operating cash flow in 4 of the past 5 years.
SUNS Yearly Net Income VS EBIT VS OCF VS FCFSUNS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2023 2024 0 100M -100M 200M 300M

1.2 Ratios

Looking at the Return On Assets, with a value of 3.92%, SUNS belongs to the top of the industry, outperforming 96.97% of the companies in the same industry.
SUNS has a Return On Equity of 5.45%. This is amongst the best in the industry. SUNS outperforms 84.85% of its industry peers.
Looking at the Return On Invested Capital, with a value of 3.18%, SUNS belongs to the top of the industry, outperforming 92.42% of the companies in the same industry.
Industry RankSector Rank
ROA 3.92%
ROE 5.45%
ROIC 3.18%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
SUNS Yearly ROA, ROE, ROICSUNS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2023 2024 2 4 6 8

1.3 Margins

With an excellent Profit Margin value of 54.18%, SUNS belongs to the best of the industry, outperforming 95.45% of the companies in the same industry.
In the last couple of years the Profit Margin of SUNS has grown nicely.
Looking at the Operating Margin, with a value of 54.18%, SUNS belongs to the top of the industry, outperforming 92.42% of the companies in the same industry.
SUNS's Operating Margin has improved in the last couple of years.
The Gross Margin of SUNS (83.07%) is better than 92.42% of its industry peers.
In the last couple of years the Gross Margin of SUNS has grown nicely.
Industry RankSector Rank
OM 54.18%
PM (TTM) 54.18%
GM 83.07%
OM growth 3Y9.05%
OM growth 5Y2.34%
PM growth 3Y17.19%
PM growth 5Y2.05%
GM growth 3Y12.79%
GM growth 5Y7%
SUNS Yearly Profit, Operating, Gross MarginsSUNS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2023 2024 20 40 60 80

3

2. Health

2.1 Basic Checks

SUNS has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, SUNS has less shares outstanding
SUNS has a worse debt/assets ratio than last year.
SUNS Yearly Shares OutstandingSUNS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2023 2024 5M 10M 15M
SUNS Yearly Total Debt VS Total AssetsSUNS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2023 2024 200M 400M 600M

2.2 Solvency

SUNS has an Altman-Z score of 1.24. This is a bad value and indicates that SUNS is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.24, SUNS belongs to the top of the industry, outperforming 90.91% of the companies in the same industry.
A Debt/Equity ratio of 0.35 indicates that SUNS is not too dependend on debt financing.
SUNS's Debt to Equity ratio of 0.35 is amongst the best of the industry. SUNS outperforms 100.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.35
Debt/FCF N/A
Altman-Z 1.24
ROIC/WACCN/A
WACCN/A
SUNS Yearly LT Debt VS Equity VS FCFSUNS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2023 2024 50M 100M 150M 200M 250M

2.3 Liquidity

SUNS has a Current Ratio of 0.92. This is a bad value and indicates that SUNS is not financially healthy enough and could expect problems in meeting its short term obligations.
SUNS has a Current ratio of 0.92. This is in the better half of the industry: SUNS outperforms 69.70% of its industry peers.
A Quick Ratio of 0.92 indicates that SUNS may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.92, SUNS is in the better half of the industry, outperforming 69.70% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.92
Quick Ratio 0.92
SUNS Yearly Current Assets VS Current LiabilitesSUNS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2023 2024 50M 100M 150M

7

3. Growth

3.1 Past

SUNS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 2846.63%, which is quite impressive.
Measured over the past years, SUNS shows a decrease in Earnings Per Share. The EPS has been decreasing by -6.82% on average per year.
The Revenue has grown by 4331.83% in the past year. This is a very strong growth!
The Revenue for SUNS have been decreasing by -23.01% on average. This is quite bad
EPS 1Y (TTM)2846.63%
EPS 3Y11.81%
EPS 5Y-6.82%
EPS Q2Q%15.29%
Revenue 1Y (TTM)4331.83%
Revenue growth 3Y-28.22%
Revenue growth 5Y-23.01%
Sales Q2Q%241.13%

3.2 Future

SUNS is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 26.96% yearly.
Based on estimates for the next years, SUNS will show a very strong growth in Revenue. The Revenue will grow by 106.19% on average per year.
EPS Next Y70.93%
EPS Next 2Y42.24%
EPS Next 3Y26.96%
EPS Next 5YN/A
Revenue Next Year306.55%
Revenue Next 2Y156.99%
Revenue Next 3Y106.19%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
SUNS Yearly Revenue VS EstimatesSUNS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 20M 40M 60M
SUNS Yearly EPS VS EstimatesSUNS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.5 1 1.5

6

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 9.17, the valuation of SUNS can be described as reasonable.
Based on the Price/Earnings ratio, SUNS is valued a bit cheaper than the industry average as 71.21% of the companies are valued more expensively.
SUNS's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.69.
The Price/Forward Earnings ratio is 7.30, which indicates a rather cheap valuation of SUNS.
SUNS's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. SUNS is cheaper than 78.79% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of SUNS to the average of the S&P500 Index (23.18), we can say SUNS is valued rather cheaply.
Industry RankSector Rank
PE 9.17
Fwd PE 7.3
SUNS Price Earnings VS Forward Price EarningsSUNS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
SUNS Per share dataSUNS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8 10

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The excellent profitability rating of SUNS may justify a higher PE ratio.
SUNS's earnings are expected to grow with 26.96% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.13
PEG (5Y)N/A
EPS Next 2Y42.24%
EPS Next 3Y26.96%

5

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 13.95%, SUNS is a good candidate for dividend investing.
SUNS's Dividend Yield is a higher than the industry average which is at 13.08.
Compared to an average S&P500 Dividend Yield of 2.34, SUNS pays a better dividend.
Industry RankSector Rank
Dividend Yield 13.95%

5.2 History

SUNS has paid a dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
SUNS Yearly Dividends per shareSUNS Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2024 2025 0.5 1

5.3 Sustainability

83.81% of the earnings are spent on dividend by SUNS. This is not a sustainable payout ratio.
DP83.81%
EPS Next 2Y42.24%
EPS Next 3Y26.96%
SUNS Yearly Income VS Free CF VS DividendSUNS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2023 2024 5M 10M 15M 20M
SUNS Dividend Payout.SUNS Dividend Payout, showing the Payout Ratio.SUNS Dividend Payout.PayoutRetained Earnings

SUNRISE REALTY TRUST INC

NASDAQ:SUNS (10/20/2025, 8:17:41 PM)

9.72

+0.31 (+3.29%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryMortgage Real Estate Investment Trusts (REITs)"
Earnings (Last)08-07 2025-08-07/bmo
Earnings (Next)11-13 2025-11-13
Inst Owners38.8%
Inst Owner Change0.01%
Ins Owners26.56%
Ins Owner Change6.41%
Market Cap130.44M
Analysts81.82
Price Target12.94 (33.13%)
Short Float %2.62%
Short Ratio4.15
Dividend
Industry RankSector Rank
Dividend Yield 13.95%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP83.81%
Div Incr Years0
Div Non Decr Years0
Ex-Date09-30 2025-09-30 (0.3)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-4.12%
Min EPS beat(2)-10.06%
Max EPS beat(2)1.81%
EPS beat(4)2
Avg EPS beat(4)-3.81%
Min EPS beat(4)-17.28%
Max EPS beat(4)10.29%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)2.66%
Min Revenue beat(2)-6.57%
Max Revenue beat(2)11.89%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)1%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-1.72%
EPS NY rev (1m)0%
EPS NY rev (3m)-4.55%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)15.51%
Revenue NY rev (1m)0%
Revenue NY rev (3m)13.8%
Valuation
Industry RankSector Rank
PE 9.17
Fwd PE 7.3
P/S 7.03
P/FCF N/A
P/OCF N/A
P/B 0.71
P/tB 0.71
EV/EBITDA N/A
EPS(TTM)1.06
EY10.91%
EPS(NY)1.33
Fwd EY13.69%
FCF(TTM)-0.21
FCFYN/A
OCF(TTM)-0.21
OCFYN/A
SpS1.38
BVpS13.73
TBVpS13.73
PEG (NY)0.13
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 3.92%
ROE 5.45%
ROCE 4.03%
ROIC 3.18%
ROICexc 3.25%
ROICexgc 3.25%
OM 54.18%
PM (TTM) 54.18%
GM 83.07%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y9.05%
OM growth 5Y2.34%
PM growth 3Y17.19%
PM growth 5Y2.05%
GM growth 3Y12.79%
GM growth 5Y7%
F-Score3
Asset Turnover0.07
Health
Industry RankSector Rank
Debt/Equity 0.35
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.92
Quick Ratio 0.92
Altman-Z 1.24
F-Score3
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)2846.63%
EPS 3Y11.81%
EPS 5Y-6.82%
EPS Q2Q%15.29%
EPS Next Y70.93%
EPS Next 2Y42.24%
EPS Next 3Y26.96%
EPS Next 5YN/A
Revenue 1Y (TTM)4331.83%
Revenue growth 3Y-28.22%
Revenue growth 5Y-23.01%
Sales Q2Q%241.13%
Revenue Next Year306.55%
Revenue Next 2Y156.99%
Revenue Next 3Y106.19%
Revenue Next 5YN/A
EBIT growth 1Y2827.71%
EBIT growth 3Y-21.72%
EBIT growth 5Y-21.21%
EBIT Next Year329.11%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y570.69%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y570.69%
OCF growth 3YN/A
OCF growth 5Y-54.51%